IIR Globe IIR Data IIR
social media icon social media icon social media icon social media icon social media icon social media icon social media icon social media icon social media icon

You are Trying to View a Premium Article

Nothing to Sneeze At! Global Pharma-Bio Sector Wraps Up $4.74 Billion in Construction Projects in 2Q17

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 811 Words
Attachment: Pharma-Biotech Completions 2Q17

SUGAR LAND--June 14, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--At the end of the second quarter of 2017, the global Pharmaceutical & Biotech Industry will have wrapped up construction on nearly $5 billion worth of reported capital and maintenance investments. Spread over 242 individual projects, construction should be complete between April 1 and June 30.

Within this article: Details on some of the major project completions from the second quarter, including those from top companies such as CSL Behring LLC, Takeda Pharma Vertrieb GmbH & Company and Elanco Animal Health.


Login or Register for Instant Access

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type:

Pricing Help?

  • Pay-Per-Article - $5.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00

All Members Receive the Following Free Resources:

  • North American Project & Gap Spending
  • Market Maps & Stats - Capital & Maintenance Activity
  • Current Economic Indicators
  • Free Daily Industrial Articles
  • Monthly Industrial Newsletter